Among The Lundquist Institute’s first high school summer fellows program cohort…
March 27th, 2025
Just before his first birthday, Christian de Virgilio, MD, was diagnosed with infantile hemolytic uremic syndrome – a condition where a baby’s red blood cells break down rapidly and renal failure sets in as a result of a life-threatening E. coli...
Antibody-based therapy is several steps closer to treat lethal mucormycosis
March 20th, 2025
Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of natural disasters.
UCLA CTSI at The Lundquist Institute Launches New Website
March 13th, 2025
UCLA CTSI launches ctsi.lundquist.org to offer an enhanced user experience and better provide the highest level of support online to The Lundquist Institute and Harbor-UCLA research community.
The Lundquist Institute Proudly Celebrates Dr. Marisela Montoya as a 2025 Los A…
March, 3rd, 2025
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is thrilled to announce that Dr. Marisela Montoya, Ed.D., IBCLC, Executive Director of the South Los Angeles Health Projects (SLAHP), has been recognized by the Los Ange
The Lundquist Institute Thanks Outgoing Board Member Dan Rosenfeld
February 7, 2025
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) extends its heartfelt thanks to Dan Rosenfeld for his invaluable contributions and years of dedicated service at the Institute.
The Lundquist Institute Appoints Joe W. Ramos, PhD, as New President & CEO
January 8th, 2025
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is pleased to announce the appointment of Joe W. Ramos, PhD, as its new President and Chief Executive Officer, effective January 21, 2025.
Donor Impact Report 2024
October 16, 2024
Your support has directly enabled us to conduct research focusing on life-threatening diseases like cancer and chronic obstructive pulmonary disease (COPD). You’ve helped us launch clinical trials that are testing cutting-edge therapies.
Dr. Shakti Singh Awarded Five-Year NIH Grant for Groundbreaking Research on Can…
September 17, 2024
Dr. Shakti Singh Awarded Five-Year NIH Grant for Groundbreaking Research on Candida auris
Lundquist Institute awarded $5.4 million CIRM grant to expand the use of stem c…
September 12, 2024
Lundquist Institute awarded $5.4 million CIRM grant to expand the use of stem cells to model human disease and extend its reach to neighboring underserved and marginalized communities
Bill Dorfman, DDS, joins Lundquist Institute Board of Directors
August 26, 2024
TLI Welcomes a New Incoming Board Member and Thanks Two Outgoing Members
The Lundquist Institute WIC Program Receives USDA 2024 WIC Breastfeeding Gold A…
August 22, 2024
The award recognizes TLI’s WIC Program for Outstanding Achievement in Supporting and Promoting Breastfeeding Among It Participants
TLI Investigator Dr. Lynda Polgreen’s Study Published in Nature Medicine Showin…
June 29, 2024
The study found that anakinra is safe and effective in improving neurobehavioral and functional outcomes for patients with Sanfilippo syndrome
TLI Investigator Dr. Marianne Gausche-Hill Co-authors New Study Revealing Cost-…
June, 11 2024
A groundbreaking study published in the Journal of the American College of Emergency Physicians Open demonstrates that adhering to national pediatric care guidelines in emergency departments (EDs) saves children’s lives and is cost-effective.
A Trailblazer Returns: 94-Year-Old Mary Burns Revisits Lundquist Institute for …
June 10, 2024
Marking a special milestone for medical research, Mary Burns, a 94-year-old trailblazer in the battle against COPD, made her return to The Lundquist Institute
TLI Receives $2.6 Million Grant from USAMRAA to Develop Wearable Biosensors
April 24, 2024
The proposed sensor has the potential to not only revolutionize COPD management but also to impact healthcare by incorporating wearable electronics into chronic disease management
The Lundquist Institute (TLI) Announces Changes to Its Board of Directors
April 9, 2024
TLI Welcomes Four Incoming Board Members and Thanks Four Outgoing Members
TLI Investigator Dr. Denise Al Alam Receives $1.5 Million Grant from CIRM to Ex…
April 2, 2024
TLI Investigator Dr. Denise Al Alam Receives $1.5 Million Grant from CIRM to Explore Genetic Defects of Lung Disease in Down Syndrome
Dr. Yoshihara Awarded $3 Million NIH R01 Grant for Diabetes Stem Cell Therapy R…
April 1, 2024
Dr. Yoshihara will investigate cutting-edge transcriptional gene regulation processes.